ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS

Correction of the patent ductus arteriosus (PDA) takes an important place in management of congenital heart defects (CHD). Untreated PDA can lead to heart failure due to left ventricular myocardial hypertrophy (LVH), pulmonary hypertension, bacterial endocarditis, pulmonary infection, and rarely the...

Full description

Bibliographic Details
Main Authors: A. N. Pakholkov, E. S. Suslov, K. A. Lashevich, A. N. Fedorchenko, V. A. Porhanov
Format: Article
Language:Russian
Published: Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2019-04-01
Series:Инновационная медицина Кубани
Subjects:
Online Access:https://inovmed.elpub.ru/jour/article/view/178
_version_ 1811331791713206272
author A. N. Pakholkov
E. S. Suslov
K. A. Lashevich
A. N. Fedorchenko
V. A. Porhanov
author_facet A. N. Pakholkov
E. S. Suslov
K. A. Lashevich
A. N. Fedorchenko
V. A. Porhanov
author_sort A. N. Pakholkov
collection DOAJ
description Correction of the patent ductus arteriosus (PDA) takes an important place in management of congenital heart defects (CHD). Untreated PDA can lead to heart failure due to left ventricular myocardial hypertrophy (LVH), pulmonary hypertension, bacterial endocarditis, pulmonary infection, and rarely the development of ductal wall aneurysm, its calcification and further rupture.It is believed that the closure of PDA is indicated in any child or adult who develops pathognomonic symptoms: expansion of the left heart; the presence of signs of pulmonary hypertension with left-right blood discharge; prior endocarditis. In asymptomatic patients with PDA accompanied by left ventricular hypertrophy closure of the duct is indicated to reduce the risk of further complications.There were various surgical methods of PDA treatment discovered in the period of the development of medical industry. Previously the most common intervention was ligation of the duct, accompanied by thoracotomy. However, in the present days the ligation of PDA is extremely rare. Endovascular occlusion has taken the lead in the modern practice. Its purpose is to close the duct with intravascular access with help of specialised tools.In this article we present a case of PDA management in a patient with clinical manifestation of PDA at the age of 35 years.
first_indexed 2024-04-13T16:25:58Z
format Article
id doaj.art-9b5c8a6d6d4643f7a7aa6e2c401055cb
institution Directory Open Access Journal
issn 2500-0268
2541-9897
language Russian
last_indexed 2024-04-13T16:25:58Z
publishDate 2019-04-01
publisher Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1
record_format Article
series Инновационная медицина Кубани
spelling doaj.art-9b5c8a6d6d4643f7a7aa6e2c401055cb2022-12-22T02:39:44ZrusScientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1Инновационная медицина Кубани2500-02682541-98972019-04-01042933175ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUSA. N. Pakholkov0E. S. Suslov1K. A. Lashevich2A. N. Fedorchenko3V. A. Porhanov4Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of HealthScientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of HealthKuban State Medical University, Ministry of Health of the Russian FederationScientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of HealthScientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of Health; Kuban State Medical University, Ministry of Health of the Russian FederationCorrection of the patent ductus arteriosus (PDA) takes an important place in management of congenital heart defects (CHD). Untreated PDA can lead to heart failure due to left ventricular myocardial hypertrophy (LVH), pulmonary hypertension, bacterial endocarditis, pulmonary infection, and rarely the development of ductal wall aneurysm, its calcification and further rupture.It is believed that the closure of PDA is indicated in any child or adult who develops pathognomonic symptoms: expansion of the left heart; the presence of signs of pulmonary hypertension with left-right blood discharge; prior endocarditis. In asymptomatic patients with PDA accompanied by left ventricular hypertrophy closure of the duct is indicated to reduce the risk of further complications.There were various surgical methods of PDA treatment discovered in the period of the development of medical industry. Previously the most common intervention was ligation of the duct, accompanied by thoracotomy. However, in the present days the ligation of PDA is extremely rare. Endovascular occlusion has taken the lead in the modern practice. Its purpose is to close the duct with intravascular access with help of specialised tools.In this article we present a case of PDA management in a patient with clinical manifestation of PDA at the age of 35 years.https://inovmed.elpub.ru/jour/article/view/178patent arterial ductendovascular occlusionintravascular access
spellingShingle A. N. Pakholkov
E. S. Suslov
K. A. Lashevich
A. N. Fedorchenko
V. A. Porhanov
ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
Инновационная медицина Кубани
patent arterial duct
endovascular occlusion
intravascular access
title ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
title_full ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
title_fullStr ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
title_full_unstemmed ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
title_short ENDOVASCULAR TREATMENT OF THE PATENT DUCTUS ARTERIOSUS
title_sort endovascular treatment of the patent ductus arteriosus
topic patent arterial duct
endovascular occlusion
intravascular access
url https://inovmed.elpub.ru/jour/article/view/178
work_keys_str_mv AT anpakholkov endovasculartreatmentofthepatentductusarteriosus
AT essuslov endovasculartreatmentofthepatentductusarteriosus
AT kalashevich endovasculartreatmentofthepatentductusarteriosus
AT anfedorchenko endovasculartreatmentofthepatentductusarteriosus
AT vaporhanov endovasculartreatmentofthepatentductusarteriosus